EP2649997
(+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for use in the treatment of myelodyspastic syndrome
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
10.12.2008EP published:
23.1.2019EP application number:
13166632.3
EPO information:
European Patent Register
Max expiry date:
9.12.2028
Title:
(+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for use in the treatment of myelodyspastic syndrome
Timeline
Today
10.12.2008EP application
23.1.2019EP Publication
Owner
Name:
Sunesis Pharmaceuticals, Inc.Address:
395 Oyster Point Boulevard, Suite 400, 94080, South San Francisco, CA, US
Inventor
Name:
Michelson, GlennAddress:
San Francisco, CA California, US
Priority
Number:
7229 PDate:
10.12.2007Country:
US
Classification
Categories:
A61K 31/4375, A61K 31/513, A61P 35/02, A61K 45/06, A61K 31/53